Compartir este artículo

A DAO for Diseases: How Vibe Bio Plans to Retool Biotech Funding

Vibe Bio’s founder wasn’t passionate about creating a DAO – but decentralizing drug research could fix a thorny, tragic problem.

Large pharmaceutical companies focus on fighting the most common (and therefore profitable) disorders. A new DAO wants to restructure incentives and boost research into rarer diseases. (Morsa/Getty Images)
Large pharmaceutical companies focus on fighting the most common (and therefore profitable) disorders. A new DAO wants to restructure incentives and boost research into rarer diseases. (Morsa/Getty Images)